Boxer Capital, LLC Cullinan Oncology, Inc. Transaction History
Boxer Capital, LLC
- $1.88 Billion
- Q3 2024
A detailed history of Boxer Capital, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Boxer Capital, LLC holds 907,895 shares of CGEM stock, worth $9.58 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
907,895
Previous 657,895
38.0%
Holding current value
$9.58 Million
Previous $11.5 Million
32.47%
% of portfolio
0.81%
Previous 0.64%
Shares
3 transactions
Others Institutions Holding CGEM
# of Institutions
147Shares Held
67.6MCall Options Held
612KPut Options Held
118K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$80.7 Million19.97% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$60.7 Million3.06% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$37.5 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$36 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.28MShares$34.6 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $481M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...